# Droperidol

## Dropel inj 2.5mg/1mL

##### 

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-----------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | IDRO                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 適應症     | Management of nausea & vomiting following surgical or diagnostic procedures.                                                                                                                                                                                                                                                                                                                                                                                                      |
| 用法用量   | Nausea and vomiting, Associated with surgical or diagnostic procedures; Prophylaxis: Adult: 2.5 mg IM/IV, followed by additional doses of 1.25 mg if potential benefit outweighs potential risk. Children 2-12 years old: maximum initial dose: 0.1 mg/kg IM/IV, additional doses should be administered with caution and if pot.ential benefit outweighs potential risk. Psychosis: 2.5-15 mg IV. Maximum single dose: 10 mg IV. 2nd dose may be given at 4-6 hr interval IM/IV. |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 禁忌       | Pre-existing CNS depression or coma, parkinsonism; known or suspected QT prolongation, including congenital long QT syndrome. Hypokalemia or hypomagnesiemia. Bradycardia.                                                                                                                                                                                                                                                                                                        |
| 副作用     | Sedation, drowsiness, weight gain, dry mouth, constipation, difficulty with micturition, blurred vision, mydriasis, restlessness, anxiety, extrapyramidal symptoms, acute dystonia, pseudoparkinsonism, akathisia, tardive dyskinesia, seizure, impaired body temperature regulation, prolongation of the QT interval, gynecomastia, orthostatic hypotension, tachycardia, arrhythmia.                                                                                            |
| 孕期建議   | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 哺乳期建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                              |

